Thomas R. Beck

Thomas R.
Beck was the founder of Dimension Therapeutics, Inc. founded in 2013, where he held the position of President, Chief Executive Officer & Director.
He also held former positions as Chairman & Chief Executive Officer of CytoMed, Inc., Chairman of Xilio Therapeutics, Inc., Director of Mersana Therapeutics, Inc. and Topaz Pharmaceuticals, Inc., Director of Vicept Therapeutics, Inc., Director & Chief Medical Officer of Promentis Pharmaceuticals, Inc., Director & Head-Research and Development of Symbiomix Therapeutics LLC, Director-Global Research & Development of UCB Pharma, Inc., Director of NeuroTherapeutics Pharma, Inc., and Director of Adagene, Inc. He was also President & Chief Operating Officer of Dyax Corp.
from 2005 to 2007, President of Enzytech, Inc., Vice President-Business & Clinical Development of Smith Kline & French Laboratories Ltd., Executive Partner of Impresa Management LLC, and Assistant Professor at Temple University School of Medicine.
Dr. Beck received his undergraduate degree from Yale University and his doctorate from Cornell University.